These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 28252970)
1. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy. Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970 [TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Lakkadwala S; Singh J Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346 [TBL] [Abstract][Full Text] [Related]
4. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma. Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036 [TBL] [Abstract][Full Text] [Related]
5. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy. Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025 [TBL] [Abstract][Full Text] [Related]
6. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720 [TBL] [Abstract][Full Text] [Related]
7. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
9. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275 [TBL] [Abstract][Full Text] [Related]
10. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme. Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951 [TBL] [Abstract][Full Text] [Related]
11. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167 [TBL] [Abstract][Full Text] [Related]
12. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment. Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416 [TBL] [Abstract][Full Text] [Related]
13. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
14. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers. Xu WW; Liu DY; Cao YC; Wang XY Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747 [TBL] [Abstract][Full Text] [Related]
15. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906 [TBL] [Abstract][Full Text] [Related]
16. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma. Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214 [TBL] [Abstract][Full Text] [Related]
17. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
18. Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy. Yang Z; Xiang B; Dong D; Wang Z; Li J; Qi X Curr Gene Ther; 2014; 14(4):289-99. PubMed ID: 25039617 [TBL] [Abstract][Full Text] [Related]
19. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845 [TBL] [Abstract][Full Text] [Related]
20. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]